209 related articles for article (PubMed ID: 22607852)
1. Rationale and design of a randomized study to determine the value of central Blood Pressure for GUIDing managEment of hypertension: the BP GUIDE study.
Sharman JE; Marwick TH; Abhayaratna WP; Stowasser M
Am Heart J; 2012 May; 163(5):761-7. PubMed ID: 22607852
[TBL] [Abstract][Full Text] [Related]
2. Randomized trial of guiding hypertension management using central aortic blood pressure compared with best-practice care: principal findings of the BP GUIDE study.
Sharman JE; Marwick TH; Gilroy D; Otahal P; Abhayaratna WP; Stowasser M;
Hypertension; 2013 Dec; 62(6):1138-45. PubMed ID: 24060891
[TBL] [Abstract][Full Text] [Related]
3. Guiding Hypertension Management Using Central Blood Pressure: Effect of Medication Withdrawal on Left Ventricular Function.
Kosmala W; Marwick TH; Stanton T; Abhayaratna WP; Stowasser M; Sharman JE
Am J Hypertens; 2016 Mar; 29(3):319-25. PubMed ID: 26152757
[TBL] [Abstract][Full Text] [Related]
4. Office and 24-h ambulatory blood pressure control by treatment in general practice: the 'Monitoraggio della pressione ARteriosa nella medicina TErritoriale' study.
Zaninelli A; Parati G; Cricelli C; Bignamini AA; Modesti PA; Pamparana F; Bilo G; Mancia G; Gensini GF;
J Hypertens; 2010 May; 28(5):910-7. PubMed ID: 20139769
[TBL] [Abstract][Full Text] [Related]
5. Central blood pressure measurement may improve risk stratification.
Sharman J; Stowasser M; Fassett R; Marwick T; Franklin S
J Hum Hypertens; 2008 Dec; 22(12):838-44. PubMed ID: 18596719
[TBL] [Abstract][Full Text] [Related]
6. ESH-ESC guidelines for the management of hypertension.
Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
[TBL] [Abstract][Full Text] [Related]
7. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
[TBL] [Abstract][Full Text] [Related]
8. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
[TBL] [Abstract][Full Text] [Related]
9. The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk.
Hemmelgarn BR; Zarnke KB; Campbell NR; Feldman RD; McKay DW; McAlister FA; Khan N; Schiffrin EL; Myers MG; Bolli P; Honos G; Lebel M; Levine M; Padwal R;
Can J Cardiol; 2004 Jan; 20(1):31-40. PubMed ID: 14968141
[TBL] [Abstract][Full Text] [Related]
10. Central blood pressure in the management of hypertension: soon reaching the goal?
Sharman JE; Laurent S
J Hum Hypertens; 2013 Jul; 27(7):405-11. PubMed ID: 23535990
[TBL] [Abstract][Full Text] [Related]
11. Twenty-four hour ambulatory blood pressure for the management of antihypertensive treatment: a randomized controlled trial.
Conen D; Tschudi P; Martina B
J Hum Hypertens; 2009 Feb; 23(2):122-9. PubMed ID: 18754021
[TBL] [Abstract][Full Text] [Related]
12. Current status of ambulatory blood pressure monitoring.
Myers MG
Can J Cardiol; 2004 Dec; 20(14):1424-8. PubMed ID: 15614335
[TBL] [Abstract][Full Text] [Related]
13. Blood pressure levels, risk factors and antihypertensive treatments: lessons from the SHEAF study.
Mallion JM; Genès N; Vaur L; Clerson P; Vaïsse B; Bobrie G; Chatellier G
J Hum Hypertens; 2001 Dec; 15(12):841-8. PubMed ID: 11773986
[TBL] [Abstract][Full Text] [Related]
14. Self-measurement of blood pressure in arterial hypertension--preliminary results from the AMPA study.
Maldonado J; Pereira T;
Rev Port Cardiol; 2009 Jan; 28(1):7-21. PubMed ID: 19388489
[TBL] [Abstract][Full Text] [Related]
15. Monitoring of antihypertensive therapy for reduction in left ventricular mass.
Hashimoto J; Imai Y; O'Rourke MF
Am J Hypertens; 2007 Nov; 20(11):1229-33. PubMed ID: 17954372
[TBL] [Abstract][Full Text] [Related]
16. Indices of pulse wave analysis are better predictors of left ventricular mass reduction than cuff pressure.
Hashimoto J; Imai Y; O'Rourke MF
Am J Hypertens; 2007 Apr; 20(4):378-84. PubMed ID: 17386343
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of benazepril on ambulatory blood pressure, left ventricular mass, diastolic filling and aortic flow in essential hypertension.
Porcellati C; Verdecchia P; Schillaci G; Boldrini F; Motolese M
Int J Clin Pharmacol Ther Toxicol; 1991 May; 29(5):187-97. PubMed ID: 1830037
[TBL] [Abstract][Full Text] [Related]
18. The therapeutic importance of home blood pressure assessment and combination antihypertensive therapy for achieving target blood pressure control: Ibaraki hypertension assessment trial.
Sato A; Watanabe S; Okubo S; Toi T; Doi T; Nakano H; Tada J; Aonuma K;
Hypertens Res; 2010 Dec; 33(12):1264-71. PubMed ID: 20927115
[TBL] [Abstract][Full Text] [Related]
19. The impact of a multidisciplinary information technology-supported program on blood pressure control in primary care.
Rinfret S; Lussier MT; Peirce A; Duhamel F; Cossette S; Lalonde L; Tremblay C; Guertin MC; LeLorier J; Turgeon J; Hamet P;
Circ Cardiovasc Qual Outcomes; 2009 May; 2(3):170-7. PubMed ID: 20031834
[TBL] [Abstract][Full Text] [Related]
20. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
